Clinical trial

The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers

NCT06786403

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusNOT_YET_RECRUITING
Study typeINTERVENTIONAL
Start date2025-03-01
PhasePHASE3
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.